Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Applied DNA Sciences Q3 EPS $(33.41) Beats $(37.50) Estimate, Sales $304.393K Miss $1.276M Estimate

Author: Benzinga Newsdesk | August 14, 2025 03:51pm
Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(33.41) per share which beat the analyst consensus estimate of $(37.50) by 10.91 percent. This is a 3441 percent decrease over earnings of $1.00 per share from the same period last year. The company reported quarterly sales of $304.393 thousand which missed the analyst consensus estimate of $1.276 million by 76.14 percent. This is a 35.62 percent decrease over sales of $472.789 thousand the same period last year.

Posted In: APDN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist